Cargando…
Early Flare-Ups of Myasthenia Gravis After Thoracoscopic Thymectomy in a Patient Recently Receiving BNT162b2 mRNA COVID-19 Vaccination
Myasthenia gravis (MG) is an autoimmune disorder characterized by abnormal neuromuscular transmission. The thymus is believed to play a key role in the pathogenesis of MG, and thymectomy has been an optional treatment for the disease. Relapse of MG after thymectomy has been reported. Exacerbations a...
Autor principal: | Dharmasaroja, Permphan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866159/ https://www.ncbi.nlm.nih.gov/pubmed/35228930 http://dx.doi.org/10.7759/cureus.21571 |
Ejemplares similares
-
Thoracoscopic thymectomy for juvenile myasthenia gravis
por: Kim, Aimee G., et al.
Publicado: (2019) -
Subxiphoid thoracoscopic thymectomy for myasthenia gravis
por: Liu, Yuanyuan, et al.
Publicado: (2021) -
Management of thoracoscopic thymectomy in a myasthenia gravis patient
por: Adate, Kavita, et al.
Publicado: (2011) -
Thoracoscopic Thymectomy for Myasthenia Gravis: Seven Years of Clinical Experience
por: Daneshvar Kakhaki, Abolghasem, et al.
Publicado: (2016) -
Transareolar uniportal thoracoscopic extended thymectomy for patients with myasthenia gravis
por: Lin, Jianbo, et al.
Publicado: (2022)